AstraZeneca's 'Storm Chaser' COVID trial misses goal but offers some hope

Drug fails to stop people developing symptomatic COVID, but may help those who have not yet come into contact with virus

New untitled screener

Exchangeis

Funds by categoryis

Funds by companyis

Morningstar performance rating overallis

Price (intraday)

greater than

Estimated results

Enter criteria and click 'Find Mutual funds' to see matching stocks